Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 5 studies | 27% ± 9% | |
| epithelial cell | 4 studies | 23% ± 8% | |
| basal cell | 3 studies | 22% ± 4% | |
| fibroblast | 3 studies | 19% ± 4% | |
| GABAergic neuron | 3 studies | 20% ± 4% | |
| glutamatergic neuron | 3 studies | 29% ± 3% |
Insufficient scRNA-seq data for expression of PTGFRN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| uterus | 100% | 9137.78 | 170 / 170 | 100% | 105.42 | 458 / 459 |
| esophagus | 100% | 6869.04 | 1445 / 1445 | 99% | 119.77 | 182 / 183 |
| intestine | 100% | 10148.91 | 966 / 966 | 99% | 60.31 | 521 / 527 |
| prostate | 100% | 4543.73 | 245 / 245 | 98% | 44.28 | 494 / 502 |
| ovary | 100% | 4654.32 | 180 / 180 | 97% | 43.64 | 415 / 430 |
| bladder | 100% | 4768.00 | 21 / 21 | 96% | 71.83 | 486 / 504 |
| pancreas | 99% | 2494.65 | 326 / 328 | 96% | 74.27 | 171 / 178 |
| stomach | 96% | 3052.58 | 344 / 359 | 97% | 58.24 | 277 / 286 |
| thymus | 99% | 2159.77 | 644 / 653 | 91% | 30.03 | 551 / 605 |
| breast | 89% | 2749.76 | 410 / 459 | 100% | 84.10 | 1113 / 1118 |
| skin | 100% | 5436.77 | 1808 / 1809 | 89% | 59.71 | 418 / 472 |
| lung | 88% | 1811.22 | 510 / 578 | 98% | 87.20 | 1128 / 1155 |
| kidney | 60% | 979.26 | 53 / 89 | 80% | 42.94 | 723 / 901 |
| brain | 56% | 784.12 | 1484 / 2642 | 82% | 40.62 | 580 / 705 |
| adrenal gland | 100% | 6343.05 | 258 / 258 | 35% | 13.39 | 81 / 230 |
| liver | 62% | 1004.77 | 141 / 226 | 60% | 21.51 | 244 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 129.20 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 29.38 | 1 / 1 |
| heart | 99% | 7293.24 | 851 / 861 | 0% | 0 | 0 / 0 |
| adipose | 92% | 2778.12 | 1111 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 84% | 24.64 | 67 / 80 |
| blood vessel | 82% | 2512.79 | 1091 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 25% | 275.81 | 60 / 241 | 0% | 0 | 0 / 0 |
| muscle | 8% | 105.08 | 65 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.83 | 1 / 29 |
| peripheral blood | 0% | 3.28 | 3 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0014905 | Biological process | myoblast fusion involved in skeletal muscle regeneration |
| GO_0034389 | Biological process | lipid droplet organization |
| GO_0009986 | Cellular component | cell surface |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PTGFRN |
| Protein name | PTGFRN protein Prostaglandin F2 receptor negative regulator (CD9 partner 1) (CD9P-1) (Glu-Trp-Ile EWI motif-containing protein F) (EWI-F) (Prostaglandin F2-alpha receptor regulatory protein) (Prostaglandin F2-alpha receptor-associated protein) (CD antigen CD315) |
| Synonyms | EWIF FPRP KIAA1436 CD9P1 |
| Description | FUNCTION: Inhibits the binding of prostaglandin F2-alpha (PGF2-alpha) to its specific FP receptor, by decreasing the receptor number rather than the affinity constant. Functional coupling with the prostaglandin F2-alpha receptor seems to occur (By similarity). In myoblasts, associates with tetraspanins CD9 and CD81 to prevent myotube fusion during muscle regeneration (By similarity). . |
| Accessions | ENST00000393203.3 A4QPA1 Q4QQP8 Q9P2B2 Q1WWL2 |
